| 2.9 |
8.6 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 1.7 |
5.0 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 1.3 |
4.0 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 1.3 |
14.1 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 1.3 |
3.8 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.7 |
4.8 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 |
10.5 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.3 |
1.0 |
GO:0048389 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) intermediate mesoderm development(GO:0048389) regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) pattern specification involved in mesonephros development(GO:0061227) regulation of hepatocyte differentiation(GO:0070366) comma-shaped body morphogenesis(GO:0072049) S-shaped body morphogenesis(GO:0072050) anterior/posterior pattern specification involved in kidney development(GO:0072098) negative regulation of glomerular mesangial cell proliferation(GO:0072125) ureter urothelium development(GO:0072190) negative regulation of glomerulus development(GO:0090194) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.2 |
1.2 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 |
0.7 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.2 |
0.8 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.2 |
0.4 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.2 |
0.5 |
GO:0003032 |
detection of oxygen(GO:0003032) regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.2 |
2.9 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
0.5 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.2 |
1.8 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 |
2.0 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.2 |
0.5 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.1 |
1.9 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 |
0.4 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) phosphate ion transmembrane transport(GO:0035435) |
| 0.1 |
0.4 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.1 |
2.5 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.5 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 |
0.5 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
1.5 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.4 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 |
0.7 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
0.8 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
1.6 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.4 |
GO:0071105 |
response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.1 |
1.1 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.1 |
0.5 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.1 |
0.4 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
0.6 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.1 |
1.0 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
1.6 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
0.3 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.5 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.1 |
0.4 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.1 |
0.1 |
GO:0060737 |
prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 0.1 |
0.4 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
1.1 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 |
6.4 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
1.7 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 |
0.8 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
1.2 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
1.0 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.0 |
1.8 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.0 |
0.2 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.0 |
0.6 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.0 |
3.0 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.3 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.0 |
0.4 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.0 |
0.4 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.0 |
0.3 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
1.7 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.8 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.6 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.0 |
0.6 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.4 |
GO:0051447 |
negative regulation of meiotic cell cycle(GO:0051447) |
| 0.0 |
0.1 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.0 |
1.0 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.0 |
0.2 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.0 |
0.4 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.4 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
1.9 |
GO:0048814 |
regulation of dendrite morphogenesis(GO:0048814) |
| 0.0 |
2.6 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
| 0.0 |
0.1 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
0.2 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.0 |
0.3 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
1.2 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
| 0.0 |
0.2 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.0 |
0.1 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.0 |
0.0 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.0 |
0.4 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.3 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.1 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.0 |
GO:0090526 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.0 |
0.6 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.0 |
0.9 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.0 |
0.1 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 |
0.4 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
